BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 2671879)

  • 1. Histopathologic parameters and DNA analysis in colorectal adenocarcinomas.
    Crissman JD; Zarbo RJ; Ma CK; Visscher DW
    Pathol Annu; 1989; 24 Pt 2():103-47. PubMed ID: 2671879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA content and its relationship with pathology and prognosis of colorectal carcinoma.
    Jiang B; Liu CG; Wang MW; Zhao DH; Li Y; Ji XL
    Chin Med J (Engl); 1992 Mar; 105(3):241-6. PubMed ID: 1395845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flow cytometric analysis of DNA abnormalities in colorectal carcinomas.
    Bocquillon PG; Daver A; Page M; Dalifard I; Chassevent A; Cellier P; Bertrand G; Larra F; George P; Chabrun B
    Bull Cancer; 1989; 76(3):291-300. PubMed ID: 2736315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A DNA cytometric proliferation index improves the value of the DNA ploidy pattern as a prognosticating tool in patients with carcinoma of the prostate.
    Ahlgren G; Lindholm K; Falkmer U; Abrahamsson PA
    Urology; 1997 Sep; 50(3):379-84. PubMed ID: 9301701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of DNA ploidy and proliferation in 309 colorectal carcinomas as determined by two-color multiparametric DNA flow cytometry.
    Zarbo RJ; Nakhleh RE; Brown RD; Kubus JJ; Ma CK; Mackowiak P
    Cancer; 1997 Jun; 79(11):2073-86. PubMed ID: 9179053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histologic parameters and DNA ploidy as predictors of survival in stage B adenocarcinoma of colon and rectum.
    Robey-Cafferty SS; el-Naggar AK; Grignon DJ; Cleary KR; Ro JY
    Mod Pathol; 1990 May; 3(3):261-6. PubMed ID: 2362936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship of nuclear DNA content to clinicopathologic features in colorectal cancer.
    Lanza G; Maestri I; Ballotta MR; Dubini A; Cavazzini L
    Mod Pathol; 1994 Feb; 7(2):161-5. PubMed ID: 8008736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prognostic value of DNA ploidy of colorectal tumor cells].
    Givel JC; de Quay N; Albe X; Vassilakos P
    Helv Chir Acta; 1989 Jan; 55(5):679-83. PubMed ID: 2715031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flow cytometric DNA analysis of poorly differentiated adenocarcinoma of the colorectum.
    Taniyama K; Suzuki H; Matsumoto M; Hakamada K; Toyama K; Tahara E
    Jpn J Clin Oncol; 1991 Dec; 21(6):406-11. PubMed ID: 1805045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA ploidy and S-phase fraction, but not p53 or NM23-H1 expression, predict outcome in colorectal cancer patients. Result of a 5-year prospective study.
    Bazan V; Migliavacca M; Zanna I; Tubiolo C; Corsale S; Calò V; Amato A; Cammareri P; Latteri F; Grassi N; Fulfaro F; Porcasi R; Morello V; Nuara RB; Dardanoni G; Salerno S; Valerio MR; Dusonchet L; Gerbino A; Gebbia N; Tomasino RM; Russo A
    J Cancer Res Clin Oncol; 2002 Dec; 128(12):650-8. PubMed ID: 12474051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prognostic significance of flow cytometric DNA analysis in colorectal cancer].
    Ando Y
    Nihon Geka Gakkai Zasshi; 1990 Nov; 91(11):1700-9. PubMed ID: 2277618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA content in renal cell carcinoma. A clinical study with special reference to tumor heterogeneity and prognosis.
    Ljungberg B
    Scand J Urol Nephrol Suppl; 1986; 100():1-47. PubMed ID: 3472340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of DNA ploidy analysis in endometrial adenocarcinoma.
    Jhala DN; Atkinson BF; Balsara GR; Hernandez E; Jhala NC
    Ann Diagn Pathol; 2001 Oct; 5(5):267-73. PubMed ID: 11598854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of DNA ploidy patterns of colorectal adenocarcinoma.
    Lin JK; Chang SC; Yang SH; Jiang JK; Chen WC; Lin TC
    Hepatogastroenterology; 2003; 50(54):1927-32. PubMed ID: 14696434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA ploidy, proliferative index, and epidermal growth factor receptor: expression and prognosis in patients with gastric cancers.
    D'Agnano I; D'Angelo C; Savarese A; Carlini M; Garofalo A; Bottari L; Santoro E; Giannarelli D; Vecchione A; Zupi G
    Lab Invest; 1995 Apr; 72(4):432-8. PubMed ID: 7723282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evaluation of prognostic parameters in colorectal carcinoma. II. Ploidy determination with flow cytometry].
    Lanza G; Maestri I; Dubini A; Gafà R
    Pathologica; 1994 Feb; 86(1):30-42. PubMed ID: 8072799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of DNA flow cytometry to paraffin-embedded archival material for the study of aneuploidy and its clinical significance.
    Hedley DW; Friedlander ML; Taylor IW
    Cytometry; 1985 Jul; 6(4):327-33. PubMed ID: 4017799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flow cytometric DNA and clinicopathologic analysis of Dukes' A&B colonic adenocarcinomas: a retrospective study.
    Visscher DW; Zarbo RJ; Ma CK; Sakr WA; Crissman JD
    Mod Pathol; 1990 Nov; 3(6):709-12. PubMed ID: 2263595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Flow cytometric DNA analysis of malignant potential in colorectal cancer].
    Ando Y; Tsuchiya A; Oki S; Sato H; Yoshida T; Kimijima I; Abe R
    Gan To Kagaku Ryoho; 1996 Jun; 23 Suppl 2():112-7. PubMed ID: 8678552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of tamoxifen on steroid hormone receptors and hormone concentration and the results of DNA analysis by flow cytometry in endometrial carcinoma.
    Nola M; Jukić S; Ilić-Forko J; Babić D; Uzarević B; Petrovecki M; Suchanek E; Skrablin S; Dotlić S; Marusić M
    Gynecol Oncol; 1999 Mar; 72(3):331-6. PubMed ID: 10053103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.